Bodey G P, McCredie K B, Keating M J, Freireich E J
Cancer. 1979 Aug;44(2):431-6. doi: 10.1002/1097-0142(197908)44:2<431::aid-cncr2820440209>3.0.co;2-4.
Thirty evaluable patients with acute leukemia (AL), aged 14 to 48-year-old received remission induction chemotherapy on a protected environment-prophylactic antibiotic program. Twenty-seven (90%) of these patients achieved complete remission and 17 remained in complete remission for 1 to 22 months. Although these patients spent 36% of their time with neutrophil counts less than 100/mm3, they spent only 20% of their time with fever. Major infection was present during only 7% of the days when neutrophil count was less than 100/mm3. No patient died of an infectious complication during remission induction therapy.
30例年龄在14至48岁的可评估急性白血病(AL)患者接受了在保护环境 - 预防性抗生素方案下的缓解诱导化疗。其中27例(90%)患者实现完全缓解,17例维持完全缓解1至22个月。尽管这些患者有36%的时间中性粒细胞计数低于100/mm³,但仅有20%的时间发热。当中性粒细胞计数低于100/mm³时,仅7%的天数出现严重感染。在缓解诱导治疗期间,无患者死于感染性并发症。